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  To  evaluate  the  potential  utility  of  a  self-expandable 
intratracheal nitinol stent with flared ends for the treatment 
of tracheal collapse in dogs, endotracheal stenting therapy 
was performed under fluoroscopic guidance in four dogs 
with severe tracheal collapse. During the 4 to 7 month follow- 
up, after stent implantation, clinical signs, including dyspnea 
and respiratory distress, dramatically improved in all dogs. 
The radiographs showed that the implanted stents improved 
the tracheal collapse, and there were no side effects such as 
collapse, shortening or migration of the stents. In conclusion, 
the  self-expandable  intratracheal  nitinol  stents  provided 
adequate  stability  to  the  trachea  and  were  effective  for 
attenuating the clinical signs associated with severe tracheal 
collapse.
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Introduction 
  Tracheal collapse in dogs, due to dorsoventrally dynamic 
narrowing of the tracheal lumen during the respiratory 
cycle, mainly occurs in toy or miniature dog breeds. The 
clinical manifestations of this condition include a classic 
“goose honk” cough, dyspnea, cyanosis, and syncope. The 
etiology of this condition is not completely known. Response 
to treatment with antitussives, antibiotics, bronchodilators, 
corticosteroids, sedatives, and oxygen, as well as other 
forms of medical management, including weight reduction, 
exercise restriction, and a non-smoking environment, 
usually is limited [7]. Surgical methods used to manage 
tracheal collapse include the application of an extraluminal 
total ring or spiral prostheses [1,2,6,8]. Although the 
recovery rate following extraluminal stabilization is about 
75% to 85%, this procedure is invasive. In addition, 
surgical reconstruction of thoracic tracheal segments is 
associated with a high mortality rate. Minimally invasive 
techniques used to treat tracheal collapse or tracheal 
stenosis in humans, dogs and cats include the implantation 
of intraluminal stainless-steel or nitinol stents [3-5,9-13]. 
Implantation of stainless-steel stents into dogs, however, 
has been associated with several complications, including 
stent migration and shortening, and granuloma formation 
[10,12]. Implantation of nitinol stents into 3 dogs with 
tracheal collapse resulted in the need for second operations 
to remove fractured stents, suggesting that these stents 
were short and weak [4,9,11]. The implantation of a 
self-expandable intratracheal nitinol stent with flared ends, 
to prevent stent migration, however, has not been assessed 
in dogs with tracheal collapse. We therefore evaluated the 
safety and efficacy of this new stent for clinical application 
in dogs with tracheal collapse.
Materials and Methods
Animals
    Four dogs were referred to the Veterinary Medical 
Teaching Hospital of the College of Veterinary Medicine at 
Konkuk University, for serious dyspnea of 4 weeks to over 
12 months duration. They had received intermittent 
medical treatment at a local clinic, but their clinical signs 
had not improved. Fluoroscopy showed dorsoventral 
narrowing of the trachea in all 4 dogs, with grades II-IV 
tracheal collapse. 
Implantation procedures
  The selected stent diameters were 10~15% greater than 
the diameter of each trachea just caudal to the larynx, as 
measured on a lateral thoracic radiograph. The length of 
each stent was the distance from the mid-cervical to the 
mid-thoracic trachea in each dog. The diameter and length 
of each stent were measured on survey lateral radiographs, 
taken when the dogs were conscious. The dogs were placed 
under general anesthesia by intravenous administration of 6 
mg/kg propofol (Hanapharm, Korea). Using a delivery 92    Joon-young Kim et al.
Table 1. Effect of self expandable intratracheal nitinol stent on clinical signs in dogs with tracheal collapse
Case Breed Age Sex Weight Grade of Stent size Site of stent Results
No. (years) (kg) tracheal collapse* (diameter-length) (clinical signs)
1 Pug 8 FS 8.5 III 10-60 mm CT-TT No coughing and dyspnea
2 Pomeranian 9 M 6.7 IV 10-80 mm CT-TT No coughing and dyspnea
3 Shih-tzu 6 FS 5.0 II 10-100 mm CT-TT No coughing and dyspnea
4 Poodle 5 M 1.6 III   8-60 mm CT-TT No coughing and dyspnea
*Grade I tracheal collapse is a 25% reduction in lumen diameter. Grade II collapse is a 50% reduction in lumen diameter. Grade III collapse
is a 75% reduction in lumen diameter. Grade IV collapse the lumen is obliterated on lateral thoracic radiograph. M: male, F: female, FS: neu-
tered female, CT‐TT: cervical trachea to thoracic trachea.
Fig. 1. Lateral radiographs before (a) and after (b) intratracheal placement of self expandable nitinol stent with flare ends in a dog with 
tracheal collapse. Collapsed trachea is extended and sustained (white arrow).
catheter (M.I.Tech., Korea), self expandable intratracheal 
nitinol stents (M.I.Tech., Korea), with flared shoulders at 
both ends to prevent migration, were inserted into the 
tracheas of the dogs under fluoroscopic control. Each dog 
was implanted with one stent, which was situated from the 
cervical to the thoracic trachea (Table 1). Medical management 
consisted of treatment with  aminophylline (10 mg/kg BW; 
Hankukmypharm, Korea), carprofen (2.2 mg/kg BW; 
Pfizer, USA) and amoxicillin-clavulanic acid (12.5 mg/kg 
BW; Pfizer, USA) orally twice daily, body weight reduction, 
and occasional oxygen using a nebulizer, beginning 7 days 
before and continuing until 4 weeks after stent implantation. 
All dogs were examined by survey radiographs and 
fluoroscopy at 2 week or 1 month intervals following 
implantation, for between 4 and 7 months. 
Results
  Technical success was achieved in all 4 dogs. Radiographs 
taken after stent implantation showed widening of the 
previously narrowed tracheal lumen in all four dogs (Fig. 
1). Soon after stent implantation, the respiratory dyspnea in 
all dogs improved dramatically, and the dogs resumed 
almost normal activity. Between 4 and 7 months after 
implantation, the dyspnea caused by tracheal collapse 
showed substantial recovery, and the radiographs showed 
no evidence of stent collapse, shortening or migration 
(Table 1).
Discussion
  In this study, intratracheal placement of the nitinol self- 
expandable stents was simple and without complications. 
In contrast to self-expanding stainless steel biliary wall 
stents and other nitinol stents [4,9-11], none of the nitinol 
expandable stents were broken, shortened or migrated. The 
flared ends of the stent likely prevented stent migration and 
increased stent stability. Dorsoventral radiographs comparing 
the length and location of each stent with the number of 
cervical and thoracic vertebrae showed no stent migration. 
The nitinol stents closely mimicked the physiological 
conditions of the airways. In addition, inflammatory 
reactions to the nitinol stents have been found to be 
minimal, without excessive accumulation of secretions Intratracheal nitinol stent for tracheal collapse in dogs    93
and without erosion through the airway walls [14]. We had 
previously implanted the same stents with flared ends into 
the trachea of normal dogs; after 2 years, necropsy 
examination showed no granulation tissue in the trachea.
  Nitinol stents show maximum expansion at body tem-
perature, with the dorsoventral forces of the collapsed 
trachea distributed equally on the surface of the stent, thus 
preventing stent collapse and migration. Our results 
demonstrated that stents located from the mid-cervical to 
the thoracic trachea increased the diameter of the entire 
cervical to thoracic tracheal area. Coughing and dyspnea 
disappeared and the dogs resumed normal activity. 
    Stent implantation is a minimally invasive, effective, 
easy and brief procedure that can be used to treat tracheal 
collapse. Nitinol stents can easily be produced with 
external dimensions tailored to fit an individual trachea or 
bronchus. Once implanted into the trachea or bronchus, the 
stent retains the same external diameter and increases the 
rigidity of the tracheobronchial wall. The nitinol stent is 
mounted, in a compressed form, over an introducing 
catheter, onto which it is fixed by a sheath. Once released 
from the introducing catheter by removal of the cover and 
exposes to body temperature, the stent expands to a preset 
diameter due to a “shape memory effect”, which prevents 
stent collapse [14]. In this study, both ends of the nitinol 
stent gradually spread outward with no stent migration. In 
addition, each dog required implantation of only one stent 
for treatment of tracheal collapse, whereas dogs required 
multiple implantations of other nitinol stents [4,9,11].
  In conclusion, we found that implantation of self- expandable 
intra-tracheal nitinol stents into dogs provided adequate 
stability to the trachea with intraluminal placement. These 
results suggest that the new nitinol stent is safe and effective 
for the treatment of dogs with tracheal collapse.
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